Serum Type I Collagen and N‐terminal Peptide of Type III Procollagen in Patients with Alcoholic Liver Disease: Relationship to Liver Histology

Abstract
This study compared, in patients with alcoholic liver disease, the serum concentration of N‐terminal peptide of type III procollagen and of a novel serum marker, type I collagen, with liver histological data and assessed the role of these markers in the diagnosis and followup of liver changes. Ninety‐six patients (mean age 51 years, 61 men and 35 women) were included. All had alcoholic liver disease diagnosed on usual clinical, biochemical, and histological criteria. Two histological scores, one for alcoholic hepatitis and one for fibrosis, were established. Serum N‐terminal peptide of type III procollagen and type I collagen were assayed by liquid phase radioimmunoassay. Significant correlations between serum type I collagen and score of fibrosis (r= 0.34, p < 0.001) and between serum N‐terminal peptide of type III procollagen and score of alcoholic hepatitis (r= 0.60, p < 0.0001) were noted. There was no significant correlation between serum aminotransferases and the score of alcoholic hepatitis. In 25 patients with alcoholic hepatitis reassessed between 3 and 6 months, serum N‐terminal peptide of type III procollagen significantfy decreased (p= 0.05) as did the score of alcoholic hepatitis, but serum type I collagen and the score of fibrosis were not modified. These serum markers of collagen metabolism could be useful for the assessment and follow‐up in patients with alcoholic liver disease.

This publication has 35 references indexed in Scilit: